Alps Advisors Inc Vir Biotechnology, Inc. Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$8.6 - $11.9 $26,866 - $37,175	3,124 Added 3.39%	95,242 $964,000
Q4 2023 Feb 14, 2024	SELL	$7.76 - $10.29 $54,327 - $72,040	-7,001 Reduced 7.06%	92,118 $926,000
Q3 2023 Nov 14, 2023	BUY	$9.14 - $24.62 $5,858 - $15,781	641 Added 0.65%	99,119 $928,000
Q2 2023 Aug 14, 2023	BUY	$23.2 - $27.29 $243,716 - $286,681	10,505 Added 11.94%	98,478 $2.42 Million
Q1 2023 May 10, 2023	SELL	$22.26 - $30.85 $49,840 - $69,073	-2,239 Reduced 2.48%	87,973 $2.05 Million
Q4 2022 Feb 14, 2023	BUY	$19.96 - $28.22 $355,168 - $502,146	17,794 Added 24.57%	90,212 $2.28 Million
Q3 2022 Nov 14, 2022	SELL	$18.26 - $31.1 $385,760 - $657,018	-21,126 Reduced 22.58%	72,418 $1.4 Million
Q2 2022 Aug 11, 2022	BUY	$19.08 - $26.7 $1.5 Million - $2.09 Million	78,374 Added 516.64%	93,544 $2.38 Million
Q1 2022 May 16, 2022	BUY	$21.19 - $40.01 $321,452 - $606,951	15,170 New	15,170 $390,000
Q4 2021 Feb 09, 2022	SELL	$30.97 - $54.03 $4.96 Million - $8.65 Million	-160,089 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$34.9 - $54.54 $373,081 - $583,032	-10,690 Reduced 6.26%	160,089 $6.97 Million
Q2 2021 Aug 11, 2021	SELL	$38.75 - $51.0 $1.38 Million - $1.82 Million	-35,637 Reduced 17.26%	170,779 $8.07 Million
Q1 2021 May 07, 2021	SELL	$26.34 - $83.07 $612,036 - $1.93 Million	-23,236 Reduced 10.12%	206,416 $10.6 Million
Q4 2020 Feb 03, 2021	BUY	$25.51 - $43.38 $1.73 Million - $2.93 Million	67,623 Added 41.74%	229,652 $6.15 Million
Q3 2020 Nov 04, 2020	BUY	$28.28 - $53.6 $33,992 - $64,427	1,202 Added 0.75%	162,029 $5.56 Million
Q2 2020 Aug 05, 2020	BUY	$27.89 - $47.86 $4.49 Million - $7.7 Million	160,827 New	160,827 $6.59 Million

Others Institutions Holding VIR

# of Institutions

218

Shares Held

87M

Call Options Held

127K

Put Options Held

1.19M

Sb Investment Advisers (Uk) LTD London, X0

16.7M
Shares

$123 Million
1.03% of portfolio
Black Rock Inc. New York, NY

16.4M
Shares

$122 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$97.2 Million
0.0% of portfolio
State Street Corp Boston, MA

5.63M
Shares

$41.6 Million
0.0% of portfolio
Orbimed Advisors LLC San Diego, CA

3.57M
Shares

$26.4 Million
0.63% of portfolio

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account